{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:07:33Z","timestamp":1788448053503,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cmi.2025.08.017","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T15:58:10Z","timestamp":1756137490000},"page":"2063-2072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The interplay between Epstein-Barr virus and cytomegalovirus reactivation following allogeneic haematopoietic cell transplantation in the era of primary cytomegalovirus prophylaxis"],"prefix":"10.1016","volume":"31","author":[{"given":"Tali","family":"Shafat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fareed","family":"Khawaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyne","family":"Daher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Febres-Aldana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri Lynn","family":"Shigle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Rondon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Champlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Spallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella J.","family":"Ariza-Heredia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katayoun","family":"Rezvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Shpall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy F.","family":"Chemaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2025.08.017_bib1","doi-asserted-by":"crossref","first-page":"682.e1","DOI":"10.1016\/j.jtct.2021.04.020","article-title":"Natural history of epstein-barr virus replication and viral load dynamics after alemtuzumab-based allogeneic stem cell transplantation","volume":"27","author":"Marzolini","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.cmi.2025.08.017_bib2","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/s41409-020-0831-7","article-title":"Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomes","volume":"55","author":"Ru","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2025.08.017_bib3","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1200\/JCO.2015.64.2405","volume":"34","author":"Styczynski","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cmi.2025.08.017_bib4","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1182\/blood.V99.12.4364","article-title":"Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation","volume":"99","author":"van Esser","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2025.08.017_bib5","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.3390\/curroncol31050211","article-title":"Epstein-Barr virus monitoring after an allogeneic hematopoietic stem cell transplant: review of the recent data and current practices in Canada","volume":"31","author":"Ratiu","year":"2024","journal-title":"Curr Oncol"},{"key":"10.1016\/j.cmi.2025.08.017_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2108","article-title":"Epstein-Barr virus related post-transplant lymphoproliferative disorder prevention strategies in allogeneic hematopoietic stem cell transplantation","volume":"30","author":"Lindsay","year":"2020","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.cmi.2025.08.017_bib7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3324\/haematol.2016.144428","article-title":"Management of Epstein-Barr virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: sixth European Conference on Infections in Leukemia (ECIL-6) guidelines","volume":"101","author":"Styczynski","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.cmi.2025.08.017_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14052","article-title":"Risk factors for post-transplant Epstein-Barr virus events in pediatric recipients of hematopoietic stem cell transplants","volume":"25","author":"Enok Bonong","year":"2021","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.cmi.2025.08.017_bib9","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s00277-019-03742-7","article-title":"Risk factors and clinical outcomes of Epstein-Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies","volume":"98","author":"Gao","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cmi.2025.08.017_bib10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12916-019-1393-7","article-title":"Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study","volume":"17","author":"Lin","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.cmi.2025.08.017_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac687","article-title":"Real-world outcomes associated with letermovir use for cytomegalovirus primary prophylaxis in allogeneic hematopoietic cell transplant recipients: a systematic review and meta-analysis of observational studies","volume":"10","author":"Vyas","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2025.08.017_bib12","article-title":"Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: a multi-centre observational study","volume":"89","author":"Hopff","year":"2024","journal-title":"J Infect"},{"key":"10.1016\/j.cmi.2025.08.017_bib13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cmi.2024.03.001","article-title":"Mortality in recipients of allogeneic haematopoietic cell transplantation in the era of cytomegalovirus primary prophylaxis: a single-centre retrospective experience","volume":"30","author":"Febres-Aldana","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.08.017_bib14","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1111\/bjh.19451","article-title":"Letermovir prophylaxis reduced cytomegalovirus reactivation and resistance post umbilical cord blood transplantation","volume":"204","author":"Yan","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cmi.2025.08.017_bib15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13045-024-01612-y","article-title":"Increased Epstein-Barr virus reactivation following prophylaxis for cytomegalovirus infection after haploidentical haematopoietic stem cell transplantation","volume":"17","author":"Kong","year":"2024","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.cmi.2025.08.017_bib16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/cid\/ciae321","article-title":"Consensus definitions of cytomegalovirus (CMV) infection and disease in transplant patients including resistant and refractory CMV for use in clinical trials: 2024 update from the transplant associated virus infections forum","volume":"79","author":"Ljungman","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.08.017_bib17","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1182\/blood-2023-182816","article-title":"A real-world efficacy of letermovir primary prophylaxis for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation in China: a single-center retrospective analysis","volume":"142","author":"Zhang","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2025.08.017_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/cid\/ciu342","article-title":"Age-specific prevalence of Epstein-Barr virus infection among Minnesota children: effects of race\/ethnicity and family environment","volume":"59","author":"Condon","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.08.017_bib19","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.10.010404","article-title":"Predictors of Epstein-Barr virus serostatus and implications for vaccine policy: a systematic review of the literature","volume":"10","author":"Winter","year":"2020","journal-title":"J Glob Health"},{"key":"10.1016\/j.cmi.2025.08.017_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064921","article-title":"Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010","volume":"8","author":"Dowd","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2025.08.017_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz037","article-title":"Infectious complications after umbilical cord blood transplantation for hematological malignancy","volume":"6","author":"Linder","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2025.08.017_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jtct.2021.01.024","article-title":"Guidelines for infection prophylaxis, monitoring and therapy in cord blood transplantation","volume":"27","author":"Olson","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.cmi.2025.08.017_bib23","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1182\/blood.V128.22.2246.2246","article-title":"Immune reconstitution after umbilical cord blood versus peripheral blood progenitor cell transplantation in adults following myeloablative conditioning","volume":"128","author":"Mehta","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2025.08.017_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1232281","article-title":"Immunology of cord blood T-cells favors augmented disease response during clinical pediatric stem cell transplantation for acute leukemia","volume":"11","author":"Borrill","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.cmi.2025.08.017_bib25","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00277-023-05596-6","article-title":"Clinical characteristics and outcomes of Epstein-Barr virus viral load after allogeneic hematopoietic stem cell transplantation","volume":"103","author":"Tsushima","year":"2024","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cmi.2025.08.017_bib26","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/tid.12618","article-title":"Dynamics of Epstein-Barr viral load after hematopoietic stem cell transplantation and effect of preemptive rituximab therapy","volume":"18","author":"Raberahona","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2025.08.017_bib27","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jtct.2021.09.021","article-title":"Risk factors for the incidence of and the mortality due to post-transplant lymphoproliferative disorder after hematopoietic cell transplantation","volume":"28","author":"Kinzel","year":"2022","journal-title":"Transplant Cell Ther"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25004148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25004148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:27:14Z","timestamp":1772882834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X25004148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1198743X25004148"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2025.08.017","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The interplay between Epstein-Barr virus and cytomegalovirus reactivation following allogeneic haematopoietic cell transplantation in the era of primary cytomegalovirus prophylaxis","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}